federal_register: 2014-28256
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-28256 | Guidance for Industry on Scale-Up Post-Approval Changes: Manufacturing Equipment Addendum; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a scale-up and post-approval changes (SUPAC) guidance for industry entitled "SUPAC: Manufacturing Equipment Addendum." This replaces the draft guidance of the same name that combined and superseded "SUPAC IR/MR: Immediate Release and Modified Release Solid Oral Dosage Forms: Manufacturing Equipment Addendum," published on January 1, 1999; and "SUPAC-SS: Nonsterile Semisolid Dosage Forms; Manufacturing Equipment Addendum," published as a draft on December 1, 1998. FDA revised the draft manufacturing equipment addenda to remove the equipment examples and to clarify the types of processes being referenced. | 2014-12-02 | 2014 | 12 | https://www.federalregister.gov/documents/2014/12/02/2014-28256/guidance-for-industry-on-scale-up-post-approval-changes-manufacturing-equipment-addendum | https://www.govinfo.gov/content/pkg/FR-2014-12-02/pdf/2014-28256.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a scale-up and post-approval changes (SUPAC) guidance for industry entitled "SUPAC: Manufacturing Equipment Addendum." This replaces the draft guidance of the same name that... |